Compare AU

Compare DRUG vs. FASI

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DRUG and FASI. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

FASI

Popularity

Low

Low

Pearlers invested

63

2

Median incremental investment

$967.00

$600.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,875.72

$2,248.08

Average age group

26 - 35

26 - 35


Key Summary

DRUG

FASI

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

FASI.AX was created on 2024-05-28 by Fidelity. The fund's investment portfolio concentrates primarily on total market equity. To achieve returns in excess of the MSCI All Country Asia ex-Japan Index NR over the medium to long term

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Fidelity Asia Active ETF (100 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

1.16 %


Key Summary

DRUG

FASI

Issuer

BetaShares

Fidelity

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

1.16 %

Price

$8.12

$11.02

Size

$191.120 million

$3.578 million

10Y return

N/A

N/A

Annual distribution/ dividend yield (5Y)

1.90 %

0.59 %

Market

ASX

ASX

First listed date

08/08/2016

30/05/2024

Purchase fee

$6.50

$6.50


Community Stats

DRUG

FASI

Popularity

Low

Low

Pearlers invested

63

2

Median incremental investment

$967.00

$600.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,875.72

$2,248.08

Average age group

26 - 35

26 - 35


Pros and Cons

DRUG

FASI

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

FASI

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home